GleamWall
中文EN

ADPT Adaptive Biotechnologies Corp

Biological Products, (No Diagnostic Substances) · Nasdaq · SEC CIK 1478320 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY17.9%
TTM net income YoY11.4%
TTM EPS YoY13.5%
Revenue 3-yr CAGR18.4%
Net income 3-yr CAGR—

Margins

Gross margin74.2%
Operating margin-16.2%
Net margin-23.7%
FCF margin-3.0%
EBITDA margin-11.6%

Returns

ROE-37.1%
ROA-12.0%
ROIC (approx.)-19.9%
Asset turnover0.51x

Leverage & solvency

Liabilities / assets73.1%
Debt / equity0.00x
Current ratio3.97x
Interest coverage-5.33x

Cash quality & payout

Operating cash flow / net income0.06x
Accruals ratio-11.3%
Payout ratio—
Capex / revenue1.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$276.98M$178.96M
Cost of revenue$71.36M$72.08M
Gross profit$205.62M$106.88M
R&D expense$93.77M$102.95M
SG&A expense$72.70M$72.81M
Operating income-$57.12M-$162.55M
Interest expense$11.78M$11.58M
Pretax income-$59.46M-$159.59M
Income tax$0$0
Net income-$59.50M-$159.49M
EBITDA-$41.12M-$145.11M
EPS (basic)-0.39-1.08
EPS (diluted)-0.39-1.08
Weighted avg. shares (diluted)151.72M147.10M
Balance sheet
Cash & equivalents$70.50M$47.92M
Short-term investments$156.49M$174.37M
Receivables$50.37M$41.73M
Inventory$9.82M$8.44M
Current assets$300.19M$283.75M
PP&E, net$34.11M$48.62M
Goodwill$118.97M$118.97M
Intangibles$1.73M$3.42M
Total assets$512.74M$539.38M
Current liabilities$89.92M$98.05M
Short-term debt$4.64M$865,000
Long-term debt$126.57M$132.41M
Total debt$131.21M$133.28M
Total liabilities$287.74M$336.89M
Shareholders' equity$218.79M$202.71M
Net debt$60.71M$85.36M
Shares outstanding153.78M147.77M
Cash flow statement
Operating cash flow-$45.99M-$95.21M
Capital expenditure$2.96M$3.66M
Free cash flow-$48.95M-$98.88M
Investing cash flow$37.95M$77.79M
Financing cash flow$30.40M$241,000
Depreciation & amortization$16.00M$17.44M
Stock-based compensation$51.48M$53.61M

Free plan shows the latest 2 periods; Pro shows all 9 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.